Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Cantargia
Cantargia and H.C. Wainwright to Host KOL Call on The Case for Nadunolimab in PDAC
June 11, 2026
Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study
June 10, 2026
Cantargia AB to Host Webcast Covering Rights Issue, Loan Agreement, and Strategic Priorities
May 28, 2026
Bulletin from the Annual General Meeting in Cantargia AB (publ)
May 21, 2026
Cantargia Publishes Interim Report for The First Quarter of 2026
May 19, 2026
Invitation to the Presentation of Cantargia’s Interim Report for Q1 2026
May 6, 2026
Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML
April 27, 2026
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
April 17, 2026
Cantargia Publishes Annual Report 2025
April 17, 2026
Notice of Annual General Meeting in Cantargia AB (publ)
April 17, 2026
1
2
Next Page
→